Tuesday, September 8

Browsing: Elritercept

Survivors

Enrollment Begins for Elritercept Phase 3 Trial in Lower-Risk MDS

By NewsCancerSeptember 8, 20260

The first patient globally has been enrolled in the phase 3 TAK-226-3001 trial (NCT07422480) evaluating elritercept (TAK-226) vs epoetin alfa-epbx…

► Necessary Cookies Always Active

Necessary cookies enable essential site features like secure log-ins and consent preference adjustments. They do not store personal data.

► Functional Cookies Remark

Functional cookies support features like content sharing on social media, collecting feedback, and enabling third-party tools.

► Analytical Cookies Remark

Analytical cookies track visitor interactions, providing insights on metrics like visitor count, bounce rate, and traffic sources.

► Advertisement Cookies Remark

Advertisement cookies deliver personalized ads based on your previous visits and analyze the effectiveness of ad campaigns.